These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24024759)

  • 21. Assessment of sotalol prescribing in a community hospital: opportunities for clinical pharmacist involvement.
    Finks SW; Rogers KC; Manguso AH
    Int J Pharm Pract; 2011 Aug; 19(4):281-6. PubMed ID: 21733016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous renal replacement therapy after cardiac surgery. Review of 85 cases.
    Lugones F; Chiotti G; Carrier M; Parent D; Thibodeau J; Ducharme B; Cardinal J; Leblanc M
    Blood Purif; 2004; 22(3):249-55. PubMed ID: 15148452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of pharmacist counseling in preventing adverse drug events after hospitalization.
    Schnipper JL; Kirwin JL; Cotugno MC; Wahlstrom SA; Brown BA; Tarvin E; Kachalia A; Horng M; Roy CL; McKean SC; Bates DW
    Arch Intern Med; 2006 Mar; 166(5):565-71. PubMed ID: 16534045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study.
    Klopotowska JE; Kuiper R; van Kan HJ; de Pont AC; Dijkgraaf MG; Lie-A-Huen L; Vroom MB; Smorenburg SM
    Crit Care; 2010; 14(5):R174. PubMed ID: 20920322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Costs of intravenous adverse drug events in academic and nonacademic intensive care units.
    Nuckols TK; Paddock SM; Bower AG; Rothschild JM; Fairbanks RJ; Carlson B; Panzer RJ; Hilborne LH
    Med Care; 2008 Jan; 46(1):17-24. PubMed ID: 18162851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of intensive care unit admissions following early resuscitation on the outcome of patients with severe sepsis and septic shock.
    Surat T; Viarasilpa T; Permpikul C
    J Med Assoc Thai; 2014 Jan; 97 Suppl 1():S69-76. PubMed ID: 24855845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of computerized physician order entry on medication prescription errors in the intensive care unit: a controlled cross-sectional trial.
    Colpaert K; Claus B; Somers A; Vandewoude K; Robays H; Decruyenaere J
    Crit Care; 2006 Feb; 10(1):R21. PubMed ID: 16469126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous infusion of vancomycin in septic patients receiving continuous renal replacement therapy.
    Covajes C; Scolletta S; Penaccini L; Ocampos-Martinez E; Abdelhadii A; Beumier M; Jacobs F; de Backer D; Vincent JL; Taccone FS
    Int J Antimicrob Agents; 2013 Mar; 41(3):261-6. PubMed ID: 23312601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT).
    Piccinni P; Cruz DN; Gramaticopolo S; Garzotto F; Dal Santo M; Aneloni G; Rocco M; Alessandri E; Giunta F; Michetti V; Iannuzzi M; Belluomo Anello C; Brienza N; Carlini M; Pelaia P; Gabbanelli V; Ronco C;
    Minerva Anestesiol; 2011 Nov; 77(11):1072-83. PubMed ID: 21597441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Who may not benefit from continuous renal replacement therapy in acute kidney injury?
    Kawarazaki H; Uchino S; Tokuhira N; Ohnuma T; Namba Y; Katayama S; Toki N; Takeda K; Yasuda H; Izawa J; Uji M; Nagata I;
    Hemodial Int; 2013 Oct; 17(4):624-32. PubMed ID: 23651363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of a pharmacy resident on hospital length of stay and drug-related costs.
    Terceros Y; Chahine-Chakhtoura C; Malinowski JE; Rickley WF
    Ann Pharmacother; 2007 May; 41(5):742-8. PubMed ID: 17440008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of patients with end-stage renal disease (ESRD) under chronic hemodialysis requiring continuous renal replacement therapy (CRRT) and patients without ESRD in acute kidney injury requiring CRRT: a single-center study.
    Jung YS; Lee J; Shin HS; Rim H
    Hemodial Int; 2012 Oct; 16(4):456-64. PubMed ID: 22541135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the time from sepsis to inception of continuous renal replacement therapy versus RIFLE criteria in patients with septic acute kidney injury.
    Chon GR; Chang JW; Huh JW; Lim CM; Koh Y; Park SK; Park JS; Hong SB
    Shock; 2012 Jul; 38(1):30-6. PubMed ID: 22706021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacist intervention in activated protein C therapy for severe sepsis: influence on health and economic outcomes.
    Chan AL; Hsieh HJ; Lin SJ
    Int J Clin Pharmacol Ther; 2009 Apr; 47(4):229-35. PubMed ID: 19356388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
    Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Pharmacist Intervention on Selection and Timing of Appropriate Antimicrobial Therapy in Septic Shock.
    Laine ME; Flynn JD; Flannery AH
    J Pharm Pract; 2018 Feb; 31(1):46-51. PubMed ID: 29278987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and economic impact of clinical pharmacist interventions regarding antimicrobials on critically ill patients.
    Leache L; Aquerreta I; Aldaz A; Monedero P; Idoate A; Ortega A
    Res Social Adm Pharm; 2020 Sep; 16(9):1285-1289. PubMed ID: 31327737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors in critically ill surgical patients requiring continuous renal replacement therapy.
    Fertmann J; Wolf H; Kuchenhoff H; Hofner B; Jauch KW; Hartl WH
    J Nephrol; 2008; 21(6):909-18. PubMed ID: 19034876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Red blood cell distribution width is an independent predictor of mortality in acute kidney injury patients treated with continuous renal replacement therapy.
    Oh HJ; Park JT; Kim JK; Yoo DE; Kim SJ; Han SH; Kang SW; Choi KH; Yoo TH
    Nephrol Dial Transplant; 2012 Feb; 27(2):589-94. PubMed ID: 21712489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacokinetics of antibiotics in continuous renal replacement therapies (CRRT)].
    Morabito S; Pistolesi V; Maggiore U; Fiaccadori E; Pierucci A
    G Ital Nefrol; 2012; 29(4):425-44. PubMed ID: 22843155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.